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The commercial milk supply on Oahu was contaminated by 
heptachlor epoxide for as long as 15 months during 1981-82 
at levels possibly as high as 1.2 ug/ g ,fat basis. Fallowing the 
contamination, several investigators attempted to evaluate 
potential adverse health outcomes, especially among infants 
and young children. However, results of the initial investiga-
tions are inconclusive due to lack of reliable measures of hep-
tachlor exposure, use of non-random sampling techniques, 
and lack of definitive health outcomes attributable to hep-
tachlor epoxide. The design of a current study to assess the 
body concentrations of heptachlor epoxide and related pesti-
cides in Hawaii is presented. The study is designed (I) to 
relate these concentrations to prior exposure via the milk con-
tamination, and (2) to assess the reliability of breast milk and 
serum pesticide concentrations as objective biological mark-
ers of body burden. No attempt is made to relate these data to 
health outcomes; instead, the findings may provide the foun-
dation for future health studies or surveillance of environmen-
tal exposure to pesticides in Hawaii. 
Introduction 
Heptachlor is a chlorinated cyclodiene pesticide that has 
been used for > 30 years for the control of termites and soil 
insects. It is metabolized primarily to heptachlor epoxide, 
which is of comparable toxicity but more stable in biological 
systems'. Despite its long use, little information exists on the 
toxicity of heptachlor in humans2• Epidemiologic studies have 
been limited mostly to pesticide manufacturers or applicators3· 
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containing heptachlor have noted central nervous system toxi-
city3·4·7, aplastic anemia and acute leukemia3·', and neuroblas-
toma in children with a history of pre- or post-natal exposure 
to chlordane8• Interpretation of these studies is limited due to 
inadequate exposure characterization, concurrent exposure to 
multiple pesticides, small study populations and short follow-
up periods of mortality studies. 
Animal studies of heptachlor have demonstrated acute cen-
tral nervous system toxicity9, subacute hepatic effects\ and 
decreased fertility and gestation length with chronic 
feeding'·". Heptachlor consumption leads to liver cancer in 
mice and possibly rats3•12•13 • Given the toxicity of heptachlor in 
animals and the recent U.S. Environmental Protection Agency 
(EPA) action14 to ban further use of heptachlor based primarily 
on animal studies, it is relevant to assess potential health 
effects in humans after instances of unintended exposure. A 
contamination of the milk supply on Oahu during the early 
1980's represents such a case of human exposure and forms 
the basis of this review of earlier health studies related to the 
contamination. The objectives and methods of a current study 
to assess body concentrations of heptachlor and related pesti-
cides in Hawaii are also presented. 
Review of the contamination 
and initial health studies 
In January 1982, the State of Hawaii Department of Health 
(DoH) found that the commercial milk supply on the island of 
Oahu was contaminated with heptachlor epoxide (HE) sub-
stantially in excess of the present Food and Drug Administra-
tion (FDA) action level of 0.1 uglg (ppm, fat basis)15•16• Subse-
quent testing of stored samples established that the contamina-
tion may have begun in the Fall of 198017-19• EPA "reasonable 
worse case estimates" suggested that between April 1981 and 
April1982, commercial milk may have contained as much as 
1.2 uglg HE. For comparison, a surveillance program of the 
entire United States commercial milk supply in 1979-1982 
found only 2 of 1,700 samples exceeding 0.12 ug/g HE'8• 
The source of HE in the milk was chopped leaves of 
pineapple plants used in dairy cattle feed on Oahu'5•20• Hep-
tachlor was used to control ants on pineapple plants and had 
been used similarly for several years without incident. Due to 
events that remain unclear, the feed was contaminated with 
heptachlor probably in 1980, resulting in excretion of HE in 
the milk of dairy cattle. The contamination was not reported 
until March 1982, after which there were 11 successful milk 
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recalls and monitoring of the milk supply to ensure that levels 
were within EPA acceptable levels. 
The potentially exposed population was the entire milk-
consuming population of Oahu. Milk from Oahu's 19 dairy 
farms (18 of which used pineapple chop for feed) was pooled 
at the only two processing facilities; therefore, contaminated 
milk was distributed throughout the island. With rare excep-
tions, milk produced on Oahu was consumed by Oahu resi-
dents and was not exported to the Neighbor Islands. Some 
speciality products, such as ice cream, were sent to the Neigh-
bor Islands; however, the level of contamination in these 
products was quite low since much of the butterfat in these 
products came from uncontaminated sources, such as from 
New Zealand. Thus, contamination was limited essentially to 
the island of Oahu. 
Earlier health studies of the contamination 
Several investigators then attempted to assess whether 
adverse health outcomes were associated with the HE contam-
ination. Three ecological studies, with exposure classification 
based on residence on Oahu during 1981-82, were undertaken 
to assess birth or perinatal outcomes. Two studies measured 
concentration of HE in human milk as an indicator of expo-
sure. The designs of these studies are summarized in Table 1. 
Burch examined trends in birth outcomes using vital 
records21 • Birth, death, and fetal death certificates for 1968-
1982 were examined for "fertility" and adverse birth out-
comes. There was no significant change in any outcome in 
1982 compared to previous years. LeMarchand et al reported 
the results of a temporal and geographical comparison of 
major congenital malformations based on hospital discharge 
data22• The investigators found that during 1970-1983, birth 
defects for Oahu were comparable to those for the United 
States, with the exception of cardiovascular malformation 
(CVM) and congenital hip dislocation (HD), which were sig-
nificantly elevated. Because the rates of CVM and HD were 
elevated before 1981, the investigators concluded that the 
increased rates were not due to the heptachlor contamination. 
Grafton used medical charts to compare perinatal outcomes of 
births at Kapiolani Medical Center for Women and Children 
(KMCWC) and Tripier Army Medical Center (T AMC) during 
1982 with those during 1978 and 197923• There was no appar-
ent change in birth weight, gestational age or sex ratio. An 
increase in jaundice during 1982 was found in some analyses, 
but it was not consistently significant. 
The studies by Burch, LeMarchand et al and Grafton were 
all limited by a lack of assessment of individual exposure. 
Dietary studies have shown that only half of adults in Hawaii 
regularly drink milk22; thus, risk estimates based on general 
population rates or samples would be attenuated due to the 
inclusion of individuals not at risk, viz non-milk drinkers. The 
studies also did not evaluate the likelihood of secular trends in 
the outcome variables, which could have confounded the tem-
poral comparisons. Finally, outcomes based on vital statistic 
reports and standard medical records may not be sufficiently 
sensitive to assess the effects of environmental exposures. 
Siegel et al analyzed samples of human milk for HE24• The 
samples were provided primarily by donors to a breast milk 
bank. Figure 1 shows the HE levels found by the Siegel study 
compared to a survey by Takei et al in Hawaii during 1979-
198()25 and a national survey conducted by Savage et al during 
1977-198326• There was a significantly different distribution of 
high and detectable HE levels in breast milk samples after the 
exposure compared to earlier population samples in Hawaii, 
thus presenting the first evidence of increased HE levels in 
Hawaii's population. However, further interpretation of the 
study is limited since subjects were self-selected and not rep-
resentative of the general population. 
Table 1 
INITIAL STUDIES OF HEPTACHLOR EPOXIDE EXPOSURE AND HEALTH OUTCOMES IN HAWAII 
Investigator 
Burch 
(21) 
leMarchand, et al 
(22) 
Grafton 
(23) 
Siegel, et al 
(24) 
Hoffman 
(26) 
Source of Data 
Birth, death, and fetal 
death certificates 
Hospital discharge data 
Medical charts from Kapiolani 
and Tripier Medical Centers 
Milk specimens provided by 
volunteers to a breast milk 
program 
Milk specimens of mothers and 
examination of children 
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Exposure ndicator 
Residence on Oahu 
during contamination 
Residence on Oahu 
during contamination 
Residence on Oahu 
during contamination 
Milk levels of heptachlor 
epoxide 
Milk levels of heptachlor 
epoxide and length of 
breast feeding 
OJtcome Measure 
Rates of adverse birth 
outcomes 
Rates of major congenital 
malformations 
Birth outcomes, e.g., birth 
weight, gestational age, or 
jaundice 
Birth weight of children 
Birth outcomes, physical 
growth and behavioral 
development through 36 
months 
(Continued) ._ 
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FIGURE 1 - Distributions of Heptachlor Epoxide 
Concentration in Breast Milk 
Comparison of the distributions of heptachlor epoxide con-
centration in breast milk (ng/g, fat basis) found in a national 
survey during 1979-198026, in a survey in Hawaii during 
1979-80 before the milk contamination episode25 , and in 
donors to a breast milk bank on Oahu after the milk contami-
nation episode••. The last distribution is based on the first 
specimen provided by each subject. 
One health study of children did present individual, 
although indirect, measures of HE exposure. Hoffman report-
ed the results of a longitudinal evaluation of 120 infants born 
during 1982 potentially exposed to HE in utero and via breast 
milk27• Breast milk was provided by 69 mothers as a measure 
of exposure to the infants. The Mean HE level in breast milk 
was 0.123 ug/g, fat basis. Canonical correlation demonstrated 
a significant association between breast milk heptachlor epox-
ide level and infant low birth weight, gestational age, jaun-
dice, and days in hospital after birth. Physical growth through 
36 months was not associated with any exposure measure. HE 
level in breast milk was associated with slower acquisition of 
behaviors at 4 and 8 months; however, no similar detrimental 
effects were found at 18 and 36 months. In fact, at 18 and 36 
months, duration of breastfeeding and behavioral development 
were positively associated. The availability of some exposure 
measures with longitudinal evaluation of health status and 
behavioral developments makes this study worthwhile, 
although flawed by small sample size and possibly a non-rep-
resentative sample. In addition, the longer-term developmen-
tal test results were inconsistent with HE exposure and pre-
sumed continued toxicity, suggesting that the apparent detri-
mental effects at 4 and 8 months may not be attributable to 
HE exposure. 
Discussion of initial studies 
Results of the initial investigations of the heptachlor con-
tamination were inconclusive due to lack of reliable measures 
of heptachlor exposure, use of non-random sampling tech-
niques, and assessment of non-specific health outcomes. The 
studies focused on transplacental passage and human milk 
consumption as the critical routes of exposure. In fact, EPA 
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FIGURE 2 - Model of Heptachlor Epoxide 
Concentration in Serum 
Toxicokinetic model of heptachlor epoxide concentration in 
the serum of an average milk-drinking adult and a child born 
in 1980. The model assumes that HE concentration in milk 
was 1.0 ug/g, fat basis, and that the contamination lasted 
one year. Hypothetical serum concentrations of HE are 
shown assuming that the half-life of HE is (a) very long or (b) 
five years. 
estimates of HE contamination in commercial milk (1.2 ug/g, 
fat basis) were an order of magnitude greater than the mean 
level in human breast milk reported by Siegel et al (0.11 ug/g, 
fat basis). None of the studies assessed dose or body concen-
trations of HE in a representative sample of the general popu-
lation. Without such information, it is not possible to define 
the truly exposed population, nor to evaluate the potential 
effect of exposure on health outcomes. 
A critical issue for future health studies or surveillance of 
the heptachlor contamination is whether the dose was suffi-
cient to have resulted in a biologically meaningful increment 
in body concentration of heptachlor epoxide. EPA estimates 
suggest exposure in individuals who regularly consumed the 
contaminated milk was substantially above that usually found 
in milk; however, the estimated dose was still below the "no 
observable effect level" in 2-year, limited dog-feeding studies, 
upon which the action level was based7·'9• Thus, health out-
comes due to exposure are likely to be subtle ( eg developmen-
tal delay among children), subclinical (eg alterations in 
immune system function), or occur after long latency (eg car-
cinogenesis). Epidemiologic evaluation of these health out-
comes is methodologically difficult, if not impossible, without 
use of a biological indicator of past dose at an individual 
level. Since HE and related pesticides are likely to persist for 
long periods in human tissue, it may be feasible to estimate 
past doses based on current human milk, serum, or adipose 
concentration?. Such determinations could serve as objective 
biological markers of past exposure. 
Study of body concentrations 
of heptachlor epoxide in Hawaii 
In response to a request for proposals by the Hawaii Hep-
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tachlor Research and Education Foundation29, investigators 
from the Mount Sinai School of Medicine of New York in 
collaboration with investigators from the KMCWC and the 
DoH are conducting a survey to determine body concentra-
tions of heptachlor epoxide and related pesticides in Hawaii's 
population. The major hypothesis is that current body concen-
tration of HE is a reliable measure of past dose and can serve 
as an objective defmition of exposure in Hawaii's population. 
The study has two components. The first component is to 
determine whether concentrations of HE and related pesticides 
are elevated among 100 lactating women residing on Oahu 
compared to 50 women each on the islands of Maui and 
Hawaii and in the states of Arkansas and North Carolina. 
Women are systematically selected postpartum on the obstet-
ric services of hospitals. They are asked to respond to a ques-
tionnaire concerning potential exposure to pesticides and to 
provide a specimen of breast milk to be analyzed for pesticide 
residues. Study hospitals include the KMCWC, Maui Memo-
rial, Hilo County Hospital, Durham County Hospital in North 
Carolina, and University Hospital of the University of 
Arkansas for the Medical Sciences in Little Rock, Arkansas. 
The Analytical Laboratories of the Colorado State University 
will determine the levels of pesticides in the milk specimens. 
The second study component is to assess concentrations of 
HE and related pesticides in the serum of 100 children 6 to 12 
years of age residing on Oahu and 50 children each on the 
islands of Maui and Hawaii, and 100 adults 20 to 60 years of 
age on Oahu. Subjects are systematically selected from among 
participants in the Hawaii Health Surveillance Survey con-
ducted by the DoH. Subjects are asked to respond to a ques-
tionnaire and to provide 7 mL of blood to be analyzed for pes-
ticide residues. Pesticide levels will be analyzed at the Mount 
Sinai laboratories. Data collection for both study components 
began in March and continued through the Winter of 1990. 
Results should be available in 1991. 
Discussion of pesticide 
body concentration study 
The study should be able to determine (1) whether body 
concentrations of heptachlor epoxide are significantly elevated 
in the population on Oahu; (2) whether any observed elevation 
is likely due to the milk contamination; and (3) whether it is 
feasible to conduct an epidemiologic study of the general pop-
ulation or to establish a surveillance program based on assess-
ment of individual exposure. 
The breast milk study component involves human milk 
because it is readily accessible and sampling is noninvasive. 
Arkansas and North Carolina were selected as Mainland com-
parison areas because pesticide use is generally highest in the 
southeast region of the countrt6• A significant elevation of 
heptachlor levels in subjects on Oahu compared to subjects 
from the aforementioned region would indicate the need for 
further medical evaluation and surveillance of the physical 
and intellectual development of infants who are breast fed 
subsequent to the interval of contamination. The result will 
also be able to address continuing concerns about the safety of 
breast feeding by mothers who consumed contaminated milk. 
The human serum study component utilizes blood because 
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it is most feasible to use serum concentrations to assess body 
concentrations of pesticides in the general population. Adi-
pose tissue contains higher concentrations of lipophilic pesti-
cides; however, obtaining adipose tissue specimens is more 
difficult and less acceptable by the subjects under study, and it 
has been determined that a reliable equilibrium ratio exists 
between adipose tissue and serum levels30• Current laboratory 
techniques can reliably measure HE in serum as low as 0.2 
ng/mL31 • It is unlikely that changes in serum levels below the 
current limit of detection would be associated with significant 
adverse health effects, although the possibility of some bio-
logical effects cannot be ruled out since health studies have 
not been done. 
The sampling scheme for the serum study component has 
been designed to determine, first, whether the age-specific 
pattern of body concentrations is indicative of exposure to the 
contaminated milk; and second, whether serum concentrations 
in particular are elevated. We have performed pharmacokinet-
ic modeling based on EPA data17-19 which suggests that chil-
dren currently 9 to 11 years of age should have the greatest 
elevation in body concentrations of HE due to the contamina-
tion of the milk supply in 1980-82 (see Figure 2). These chil-
dren - 1 to 3 years of age at the time of the contamination -
would have consumed relatively large amounts of cows milk. 
Younger children were not as likely to have been exposed to 
contaminated cows' milk, and adults would have lower levels 
based on their larger body mass and lower milk consumption 
on the average. Furthermore, levels in adults would reflect 
longer life time exposures which could obscure elevations due 
to the contamination of episode per se. Thus, the sample of 
adults is useful in providing an estimate of the range of body 
concentrations in the general population, and what proportion 
of the population has reliably detectable serum concentration 
of HE. For comparison, a study based on the second National 
Health and Nutrition Examination Survey found that only 
2.5% of the United States adult population had HE serum lev-
els above the 1 ng/mL detection limit in that surveyl2 • The cur-
rent study will be able to determine whether serum HE level is 
a reliable quantitative measure to distinguish between exposed 
and unexposed populations, a crucial element for designing 
future surveillance or conducting etiological research. 
A recent survey by the DoH found that the most pervasive 
public health concern of Hawaii's population is chemical pol-
lution "due to the contamination of food and water by pesti-
cides and other man-made chemicals33". This concern has 
arisen in part because of episodes such as the aforementioned 
heptachlor contamination of milk on Oahu. Such episodes pre-
sent a challenge to clinical and public health practitioners to 
understand and interpret the risk for their patients and the pub-
lic at large. The current study of heptachlor epoxide and relat-
ed pesticide levels in the general population of Hawaii would 
contribute to our understanding of potential risk due to pesti-
cides in the environment. 
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studies and to further evaluate the mechanisms of carcino-
genic action and the characteristics of exposure that lead to 
these effects." 
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